Hotchkis & Wiley Capital Management’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.8M Buy
481,520
+64,590
+15% +$1.53M 0.04% 195
2025
Q4
$10.3M Sell
416,930
-4,780
-1% -$127K 0.03% 233
2025
Q3
$12M Buy
421,710
+129,270
+44% +$3.5M 0.04% 211
2025
Q2
$7.28M Buy
292,440
+113,020
+63% +$3.18M 0.02% 319
2025
Q1
$5.56M Buy
+179,420
New +$5.98M 0.02% 363

Other funds holding ASTH

Hotchkis & Wiley Capital Management's ASTH Position: Q1 2026 in Review

Hotchkis & Wiley Capital Management increased its Astrana Health (ASTH) stake by 15% in Q1 2026, buying an estimated $1.53M and bringing the position to 481,520 shares worth $11.8M. The position accounts for 0.04% of the portfolio, ranked #195.

Hotchkis & Wiley Capital Management first reported a position in ASTH in Q1 2025 and has held it in 5 quarters since. The position peaked at $12M in Q3 2025. 171 funds tracked by Wall St. Rank hold ASTH as of Q1 2026.

  • Hotchkis & Wiley Capital Management held 481,520 shares of Astrana Health worth $11.8M as of Q1 2026.
  • Hotchkis & Wiley Capital Management bought 64,590 Astrana Health shares in Q1 2026, an estimated $1.53M.
  • Astrana Health made up 0.04% of Hotchkis & Wiley Capital Management's portfolio in Q1 2026, its #195 holding.
  • Hotchkis & Wiley Capital Management first reported a position in Astrana Health in Q1 2025 and has held it in 5 quarters since.
  • Hotchkis & Wiley Capital Management's Astrana Health position peaked at $12M in Q3 2025.
  • 171 funds tracked by Wall St. Rank held Astrana Health as of Q1 2026.

Based on Hotchkis & Wiley Capital Management's 13F filing for Q1 2026, filed 15 May 2026.